News
|
Markets
|
watchlist
|
Menu
ABBOTT PARK
Related Articles
Abbott Board Must Face Depakote Investor Suit, Judge Says
14 days ago
Abbott’s Profit Rose on Nutritional Product Sales
2 months ago
AbbVie Said to Fire Heart Sales Force as Generics Compete
2 months ago
Basel Pharma Converges With Art as City Sings Bank Blues
3 months ago
Abbott’s Heart Valve Gets Mixed Review From FDA Advisers
3 months ago
Abbott MitraClip Study Data Isn’t Easy to Interpret
3 months ago
Overseas Tax Savings for U.S. Drugmakers Under Threat
3 months ago
Liberty Medical Files for Chapter 11 Bankruptcy
4 months ago
Abbott Forecasts 2013 Earnings That Meets Analyst Estimates
5 months ago
Heart-Block Test Could Bring Volcano, St. Jude $2 Billion
5 months ago
AbbVie Rises on First Day of Trading After Abbott Spinoff
6 months ago
Insider Mulls Suicide as Health Care Tipping Wave Grows
7 months ago
Abbott’s Partner Ends Trial of Kidney Failure Drug
8 months ago
Abbott’s Hepatitis C Drugs Clear Virus in 99% of Patients
8 months ago
J&J Wins Trial Challenging Abbott Patents on Psoriasis Drug
9 months ago
Abbott’s Humira Backed by FDA Advisory Panel for Colitis
10 months ago
Abbott Profit Tops Estimates as Humira Drug Sales Climb
11 months ago
Abbott’s New Use for Top Drug Humira Delayed by U.S.
13 months ago
Human Genome Most Lucrative on Record Biotech Premiums
14 months ago
Abbott Breakup Plans Are on Target as Profit Tops Estimates
14 months ago
Show More News
PHOTOS